Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae

Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice

(2022) Qiuyue Hu et al.   Frontiers in Pharmacology

Gut microbiota-derived metabolites are novel targets for improving insulin resistance

(2022) Rosana MC Bastos et al.   World Journal of Diabetes

Anti-Inflammatory Action and Mechanisms of Resveratrol

(2021) Tiantian Meng et al.   MOLECULES

Resveratrol Improves Liver Steatosis and Insulin Resistance in Non-alcoholic Fatty Liver Disease in Association With the Gut Microbiota

(2021) Fan Du et al.   Frontiers in Microbiology

Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset

(2021) Iñaki Milton-Laskibar et al.   Nutrients

Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis

(2020) Pan Wang et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data

(2020) Jasmine Chong et al.   Nature Protocols

Effect of resveratrol on intestinal tight junction proteins and the gut microbiome in high-fat diet-fed insulin resistant mice

(2020) Kaiting Chen et al.   INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION

Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in nonalcoholic fatty liver disease

(2020) Xiao Chen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: Ready for prime time?

(2020) Münevver Demir et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders

(2020) Judith Aron-Wisnewsky et al.   Nature Reviews Gastroenterology & Hepatology

Gut microbiota in human metabolic health and disease

(2020) Yong Fan et al.   NATURE REVIEWS MICROBIOLOGY

The Gut Microbiota and Inflammation: An Overview

(2020) Zahraa Al Bander et al.   International Journal of Environmental Research and Public Health

The Gut Microbiome and Individual-Specific Responses to Diet

(2020) Avner Leshem et al.   mSystems

Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease

(2019) Ki Tae Suk et al.   Expert Review of Gastroenterology & Hepatology

Resveratrol-induced gut microbiota reduces obesity in high-fat diet-fed mice

(2019) Pan Wang et al.   INTERNATIONAL JOURNAL OF OBESITY

Effects of dietary fat on gut microbiota and faecal metabolites, and their relationship with cardiometabolic risk factors: a 6-month randomised controlled-feeding trial

(2019) Yi Wan et al.   GUT

Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system

(2019) Mengting Chen et al.   CLINICAL NUTRITION

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

(2019) Evan Bolyen et al.   NATURE BIOTECHNOLOGY

Deciphering the Anti-obesity Benefits of Resveratrol: The “Gut Microbiota-Adipose Tissue” Axis

(2019) Liyuan Zhou et al.   Frontiers in Endocrinology

Gut Microbiota and Risk of Persistent Nonalcoholic Fatty Liver Diseases

(2019) Han-Na Kim et al.   Journal of Clinical Medicine

Factors affecting the composition of the gut microbiota, and its modulation

(2019) Nihal Hasan et al.   PeerJ

Distinct gut metagenomics and metaproteomics signatures in prediabetics and treatment-naïve type 2 diabetics

(2019) Huanzi Zhong et al.   EBioMedicine

THE ROLE OF THE GUT MICROBIOTA IN LIVER DISEASE

(2019) Somaya A. M. Albhaisi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Beneficial Effects of Dietary Polyphenols on Gut Microbiota and Strategies to Improve Delivery Efficiency

(2019) Amit Kumar Singh et al.   Nutrients

Gut Microbiota as a Therapeutic Target for Metabolic Disorders

(2018) Hirofumi Okubo et al.   CURRENT MEDICINAL CHEMISTRY

Aberrant intestinal microbiota in individuals with prediabetes

(2018) Kristine H. Allin et al.   DIABETOLOGIA

Resveratrol, Metabolic Syndrome, and Gut Microbiota

(2018) Alice Chaplin et al.   Nutrients

Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease

(2017) Feng Shen et al.   Hepatobiliary & Pancreatic Diseases International

Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments

(2017) Hironori Kitade et al.   Nutrients

Microbiome Datasets Are Compositional: And This Is Not Optional

(2017) Gregory B. Gloor et al.   Frontiers in Microbiology

Resveratrol and caloric restriction prevent hepatic steatosis by regulating SIRT1-autophagy pathway and alleviating endoplasmic reticulum stress in high-fat diet-fed rats

(2017) Shibin Ding et al.   PLoS One

Effect of specific amino acids on hepatic lipid metabolism in fructose-induced non-alcoholic fatty liver disease

(2016) Prasanthi Jegatheesan et al.   CLINICAL NUTRITION

The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)

(2016) Elena Buzzetti et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

DADA2: High-resolution sample inference from Illumina amplicon data

(2016) Benjamin J Callahan et al.   NATURE METHODS

Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study

(2016) Zhen-Ya Lu et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The gut microbiome in health and in disease

(2015) Andrew B. Shreiner et al.   CURRENT OPINION IN GASTROENTEROLOGY

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial

(2015) Shihui Chen et al.   DIGESTIVE AND LIVER DISEASE

Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease

(2015) Weiwei Jiang et al.   Scientific Reports

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease

(2014) Forouzan Faghihzadeh et al.   NUTRITION RESEARCH

Understanding the role of gut microbiome in metabolic disease risk

(2014) Yolanda Sanz et al.   PEDIATRIC RESEARCH

Impact of Polyphenols and Polyphenol-Rich Dietary Sources on Gut Microbiota Composition

(2013) Usune Etxeberria et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Role of Dietary Polyphenols and Inflammatory Processes on Disease Progression Mediated by the Gut Microbiota

(2013) J. Alfredo Martínez et al.   REJUVENATION RESEARCH

The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

(2012) Christian Quast et al.   NUCLEIC ACIDS RESEARCH

The impact of nutrition on the human microbiome

(2012) Harry J Flint   NUTRITION REVIEWS

Bioavailability of resveratrol

(2011) Thomas Walle   Annals of the New York Academy of Sciences

Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet

(2010) M. T. Macarulla et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

The role of the gut microbiota in nonalcoholic fatty liver disease

(2010) Ahmed Abu-Shanab et al.   Nature Reviews Gastroenterology & Hepatology

Effect of 6-month nutritional intervention on non-alcoholic fatty liver disease

(2009) Maria Cristina Elias et al.   NUTRITION